Disposable Blood Bag Market Size, Share, Manufacturers 2030

Disposable Blood Bag Market

Disposable Blood Bag Market By Product (Blood Collection Bags and Blood Transfusion Bags), By End User (Blood Banks, Hospitals, NGOs, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030

Category: Healthcare Report Format : PDF Pages: 203 Report Code: ZMR-6827 Published Date: Apr-2023 Status : Published
Market Size in 2022 Market Forecast in 2030 CAGR (in %) Base Year
USD 225.1 Million USD 372.5 Million 6.5% 2022

 

Industry Prospective:

The global disposable blood bag market size was worth around USD 225.1 Million in 2022 and is predicted to grow to around USD 372.5 Million by 2030 with a compound annual growth rate (CAGR) of roughly 6.5% between 2023 and 2030. The report analyzes the global disposable blood bag market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the disposable blood bag market.    

Global Disposable Blood Bag Market SizeRequest Free Sample

Disposable Blood Bag Market: Overview

Biomedical devices known as disposable blood bags are used to gather, store, transport, and transfuse blood and its constituent parts. They are made of biocompatible PVC that has been blended with the proper additives so that it won't conflict with blood constituents. Glass bottles must be thoroughly cleaned, rinsed, and autoclaved, and there is a risk of breakage at any time, so disposable blood bags are favored over glass bottles. Disposable blood bags also aid in the separation of blood components that are used to treat a variety of blood diseases, including plasma, platelets, and cryoprecipitate.

Key Insights

  • As per the analysis shared by our research analyst, the global disposable blood bag market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2023-2030).
  • In terms of revenue, the global disposable blood bag market size was valued at around USD 225.1 million in 2022 and is projected to reach USD 372.5 million, by 2030.
  • The growing cases of cardiovascular diseases are further expected to fuel surgical procedures, thereby boosting the requirement for disposable blood bags.
  • Based on the product, the blood transfusion segment is expected to dominate the market over the forecast period.
  • Based on the end user, the hospital segment is expected to account for the largest market share during the forecast period.
  • Based on region, North America is expected to dominate the market during the forecast period.

Global Disposable Blood Bag MarketRequest Free Sample

Disposable Blood Bag Market: Growth Drivers

An increasing amount of collisions and injuries from traffic drives the market growth

A surge in automobile crashes is anticipated to increase demand for blood and blood products during the analysis period. The World Health Organization estimates that 1.3 million people have their lives cut short as a result of transportation accidents each year. There are an extra 20 to 50 million people who suffer non-fatal injuries. Road accidents cost the bulk of nations 3% of their GDP. Despite possessing about 60% of the world's cars, low- and middle-income countries are responsible for 93% of all traffic fatalities. The injured lose a lot of blood in these accidents, so an increase in traffic accidents is predicted to have a significant impact on the global disposable bags market growth.

Disposable Blood Bag Market: Restraints

The lack of sufficient infrastructure hinders the industry from growing                        

The absence of adequate healthcare infrastructure for blood collection, storage, and distribution across various low-income nations is anticipated to significantly restrain the development of the global disposable blood bags market over the forecast period.

Disposable Blood Bag Market: Opportunities

A rise in the frequency of diseases associated with blood is expected to provide a lucrative opportunity

Due to the rising prevalence of blood-related diseases and the increasing demand for blood collection and transfer bags, it is anticipated that the global disposable blood bag industry will grow during the forecasted period. According to the US National Heart Lung and Blood Institute, millions of people are impacted by blood disorders each year. Hemophilia, anemias, venous thromboembolism, and other bleeding disorders impact red and white blood cells, platelets, bone marrow, vascular endothelium, and plasma proteins.

These conditions can be inherited or acquired. These conditions can cause abnormal blood cell activity, which may result in disease or have an effect on everyone's health. Around 100,000 Americans are said to have sickle cell disease (SCD), according to the US CDC. One out of every 365 Black or African American babies born has SCD. One in every 16,300 infants born to Hispanic Americans has SCD. About 1 in every 13 Black or African-American newborns has the sickle cell trait. Therefore, the market for disposable blood bags is expected to grow due to the rising incidence of blood-related disorders.

Disposable Blood Bag Market: Challenges

The risk of disease spread could impede market expansion

The danger of transmitting HIV, hepatitis B or C, and sepsis is increased when the plastic bags are used unevenly or are contaminated. For instance, hepatitis C is the most common chronic bloodborne disease spread by blood transfusion. Without a robust healthcare infrastructure for blood collection, storage, and delivery across many low-income countries, these risks rise. During the projection period, this is likely to restrain the development of the disposable bag market globally.

Disposable Blood Bag Market: Segmentation

The global disposable blood bag industry is segmented based on the product, end user, and region.

Based on the product, the global market is bifurcated into blood collection bags and blood transfusion bags. The blood transfusion segment is expected to dominate the market over the forecast period. Blood products are intravenously transferred into a recipient's circulation using blood transfusion bags. The procedure of a blood transfusion is used to restore missing blood components in several medical conditions. The demand for blood transfusion bags is expected to rise as the number of infectious and persistent diseases, along with the number of surgical operations, rises. Nearly 21 million blood components are transfused annually in the US, according to the American National Red Cross.

Additionally, over 118.5 million blood donations will be gathered in 2020 for use in transfusions of sick patients, according to data from the World Health Organization (WHO). In high-income countries, which are home to 16% of the world's population, 40% of these are gathered globally. According to the WHO, there have been 7.8 million more voluntary, unpaid blood donations recorded between 2013 and 2018. This rise in blood donation consciousness is anticipated to drive the market expansion for transfusion bags.

Based on the end user, the market is segmented into blood banks, hospitals, NGOs, and others. The hospital segment is expected to account for the largest market share during the forecast period because of the increase in surgical procedures. Additionally, it is anticipated that the segment will expand as a result of the rise in blood disorders, the expansion of the healthcare sector, and the rising number of hospitals and clinics being built. As per the National Institute of Health, around 40 to 50 million major surgeries are done annually in the USA, and 20 million in Europe, for a startling total of 310 million worldwide. Thus, these facts support the growth of the market development.

Recent Developments:

  • In April 2021, for USD 55.2 million, Grifols acquired the seven US plasma exchange facilities from Kedrion. Grifols anticipates having immediate access to the plasma obtained in these facilities, which acquire about 240,000 liters annually, as a result of the acquisition.
  • In January 2021, a definitive deal was reached for the purchase of privately held Cardiva Medical Inc. by Haemonetics Corporation. In the vast and expanding interventional cardiology portfolio, including disposable blood bags, the purchase is likely to aid Haemonetics in diversifying and enhancing its hospital offerings.

Disposable Blood Bag Market: Report Scope

Report Attributes Report Details
Report Name Disposable Blood Bag Market Research Report
Market Size in 2022 USD 5.32 Billion
Market Forecast in 2030 USD 24.53 Billion
Growth Rate CAGR of 21.5%
Number of Pages 203
Key Companies Covered Macopharma, TERUMO BCT, INC., Fresenius Kabi India Pvt. Ltd, Demophorius Healthcare Ltd, Grifols, S.A., Neomedic International SL, Teleflex Incorporated, Qingdao Sinoland International Trade Co., Ltd, JMS Co.Ltd, KAWASUMI LABORATORIES. INC., AdvaCare Pharma, Polymedicure, Coloplast Corp, Innvol., The Metrix Company, BL Lifesciences, and SURU INTERNATIONAL PVT. LTD among others.
Segments Covered By Product, By End User, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2017 to 2021
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Disposable Blood Bag Market: Regional Analysis

North America is expected to dominate the market during the forecast period

North America is expected to dominate the global disposable blood bag market during the forecast period. The market will experience profitable development as a result of factors like the increased use of blood tests and the prevalence of numerous chronic diseases and blood-related disorders in the region. Additional factors that may have a positive effect on market development include the presence of a well-developed & equipped healthcare infrastructure, increased blood donation activities, and government initiatives to promote the use of disposable blood bags to prevent infections. Over 36,000 units of red blood cells, 7,000 units of platelets, and 10,000 units of plasma are required every day in the United States, according to data from the American National Red Cross that was released in 2018.

In the United States, an estimated 6.8 million people give blood. On the other side, the prevalence of chronic diseases is rising here over time. For instance, the International Agency for Research on Cancer Society stated that there were 2.28 million cancer cases in the United States in 2020, and that number is expected to rise to 3.12 million by 2040. North America is therefore expected to experience profitable development in the future as a result of the presence of all market-driving factors in the region.

Disposable Blood Bag Market By RegionRequest Free Sample

Asia Pacific is anticipated to experience the fastest rate of growth for disposable blood bags during the anticipated timeframe. The Asia Pacific disposable blood bag market is primarily driven by an increase in accidents as well as an increase in blood transit and transfusion procedures. China and India, two of the region's developing countries, will gradually add to the growth of the Asia Pacific disposable blood bag market.

Disposable Blood Bag Market: Competitive Analysis

The global disposable blood bag market is dominated by players like:

  • Macopharma
  • TERUMO BCT INC.
  • Fresenius Kabi India Pvt. Ltd
  • Demophorius Healthcare Ltd
  • Grifols
  • S.A.
  • Neomedic International SL
  • Teleflex Incorporated
  • Qingdao Sinoland International Trade Co. Ltd
  • JMS Co.Ltd
  • KAWASUMI LABORATORIES. INC.
  • AdvaCare Pharma
  • Polymedicure
  • Coloplast Corp
  • Innvol.
  • The Metrix Company
  • BL Lifesciences
  • SURU INTERNATIONAL PVT. LTD

The global disposable blood bag market is segmented as follows:

By Product

  • Blood Collection Bags
  • Blood Transfusion Bags

By End User

  • Blood Banks
  • Hospitals
  • NGOs
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Blood bag systems are designed for transfusion, transportation, storage, and collection of human blood and blood-associated products. These are the disposable biomedical products utilized heavily by the government, blood banks, hospitals, and non-government organizations to collect blood during donation programs.

The growing demand for blood transfusion procedures, along with the surge in trauma incidents globally, is likely to thrive the growth of the global disposable blood bag market. In addition, the growing number of road accidents and traffic injuries is further scaling up the growth of the global disposable blood bag market exponentially.

According to the report, the global market size was worth around USD 225.1 million in 2022 and is predicted to grow to around USD 372.5 million by 2030.

The global disposable blood bag market is expected to grow at a CAGR of 6.5% during the forecast period.

The global disposable blood bag market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market owing to the rising number of fatalities due to road accidents.

The global disposable blood bag market is dominated by players like Macopharma, TERUMO BCT, INC., Fresenius Kabi India Pvt. Ltd, Demophorius Healthcare Ltd, Grifols, S.A., Neomedic International SL, Teleflex Incorporated, Qingdao Sinoland International Trade Co., Ltd, JMS Co.Ltd, KAWASUMI LABORATORIES. INC., AdvaCare Pharma, Polymedicure, Coloplast Corp, Innvol., The Metrix Company, BL Lifesciences and SURU INTERNATIONAL PVT. LTD among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed